A pilot study of recombinant interleukin-2 for treatment of chronic hepatitis C.

Pardo M, Castillo I, Oliva H, Fernández-Flores A, Bárcena R, Antje de Peuter M,Carreño V. Hepatology 1997; 26: 1318-1321.